Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_assertion type Assertion NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_head.
- NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_provenance.
- NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_assertion evidence source_evidence_literature NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_provenance.
- NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_assertion SIO_000772 19549232 NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_provenance.
- NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_assertion wasDerivedFrom befree-2016 NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_provenance.
- NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_assertion wasGeneratedBy ECO_0000203 NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_provenance.